To examine the prognostic impact of S100A4 in patients receiving adjuvant treatment, we investigated the expression in tumor samples from patients included in a phase III randomized study that compared surgery alone with surgery and 5‐fluorouracil/levamisole in stage II or III colon and rectal cancer patients 19. The gene discussed is S100A4; the disease is rectal cancer.